Stay updated on Daratumumab for Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab for Multiple Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a change in the site interface/version rather than the underlying study details.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedAdded the topic 'Multiple myeloma' to the page and introduced a new external resource link to the Genetic and Rare Diseases Information Center under resources.SummaryDifference0.2%

- Check50 days agoChange DetectedThe site revision in the footer was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedResults have been posted for this study, including MRD negativity rates after ASCT and after consolidation/maintenance, progression-free and overall survival, overall response rate, adverse events, and MRD testing methods, with corresponding data submission dates.SummaryDifference2%

- Check79 days agoChange DetectedResults Submitted is now displayed on the study page, replacing the previous 'No Results Posted' status.SummaryDifference0.1%

Stay in the know with updates to Daratumumab for Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.